J05 Legato-hd study: a phase 2 study assessing the efficacy and safety of laquinimod as a treatment for huntington disease

Ralf Reilmann; Mark Forrest Gordon; Karen E Anderson; Andrew Feigin; Sarah J Tabrizi; Blair R Leavitt; Julie C Stout; Paola Piccini; Gail Rynkowski; Rita Volkinshtein; Juha Savola

doi:10.1136/jnnp-2018-EHDN.265

Article info

Clinical therapeutics

J05 Legato-hd study: a phase 2 study assessing the efficacy and safety of laquinimod as a treatment for huntington disease

Authors

Ralf Reilmann 1George-Huntington-Institute Muenster & Department of Neurodegenerative Diseases and Hertie Institute for Clinical Brain Research University of Tuebingen, Germany PubMed articles Google scholar articles
Mark Forrest Gordon 2Research and Development Teva Pharmaceuticals Ltd, Frazer PA USA PubMed articles Google scholar articles
Karen E Anderson 3MedStar Georgetown University Hospital & Georgetown University Medical Center Washington DC, USA PubMed articles Google scholar articles
Andrew Feigin 4NYU Langone Health New York, NY, USA PubMed articles Google scholar articles
Sarah J Tabrizi 5UCL Institute of Neurology London, UK PubMed articles Google scholar articles
Blair R Leavitt 6Centre for Molecular Medicine and Therapeutics University of British Columbia, Vancouver BC CAN PubMed articles Google scholar articles
Julie C Stout 7Monash University Melbourne Australia PubMed articles Google scholar articles
Paola Piccini 8Imperial College London UK PubMed articles Google scholar articles
Gail Rynkowski 2Research and Development Teva Pharmaceuticals Ltd, Frazer PA USA PubMed articles Google scholar articles
Rita Volkinshtein 2Research and Development Teva Pharmaceuticals Ltd, Frazer PA USA PubMed articles Google scholar articles
Juha Savola 2Research and Development Teva Pharmaceuticals Ltd, Frazer PA USA PubMed articles Google scholar articles

Citation

Reilmann R, Gordon MF, Anderson KE, et al

J05 Legato-hd study: a phase 2 study assessing the efficacy and safety of laquinimod as a treatment for huntington disease

Journal of Neurology, Neurosurgery & Psychiatry 2018;89:A99.

Publication history

First published September 12, 2018.

Online issue publication

May 13, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password